120 related articles for article (PubMed ID: 28078913)
61. Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: a promising approach for the treatment of defective telomerase disorders.
Egusquiaguirre SP; Manguán-García C; Pintado-Berninches L; Iarriccio L; Carbajo D; Albericio F; Royo M; Pedraz JL; Hernández RM; Perona R; Igartua M
Eur J Pharm Biopharm; 2015 Apr; 91():91-102. PubMed ID: 25660910
[TBL] [Abstract][Full Text] [Related]
62. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
[TBL] [Abstract][Full Text] [Related]
63. Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro.
Sun HP; Su JH; Meng QS; Yin Q; Zhang ZW; Yu HJ; Zhang PC; Wang SL; Li YP
Acta Pharmacol Sin; 2016 Jul; 37(7):941-9. PubMed ID: 27133295
[TBL] [Abstract][Full Text] [Related]
64. Enhanced delivery of Paclitaxel using electrostatically-conjugated Herceptin-bearing PEI/PLGA nanoparticles against HER-positive breast cancer cells.
Yu K; Zhao J; Zhang Z; Gao Y; Zhou Y; Teng L; Li Y
Int J Pharm; 2016 Jan; 497(1-2):78-87. PubMed ID: 26617314
[TBL] [Abstract][Full Text] [Related]
65. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo.
Song Z; Feng R; Sun M; Guo C; Gao Y; Li L; Zhai G
J Colloid Interface Sci; 2011 Feb; 354(1):116-23. PubMed ID: 21044788
[TBL] [Abstract][Full Text] [Related]
66. The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.
Luo YY; Xiong XY; Cheng F; Gong YC; Li ZL; Li YP
Int J Biol Macromol; 2017 Dec; 105(Pt 1):711-719. PubMed ID: 28716749
[TBL] [Abstract][Full Text] [Related]
67. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
Chen YC; Hsieh WY; Lee WF; Zeng DT
J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
[TBL] [Abstract][Full Text] [Related]
68. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Mistry NP; Desai JL; Thakkar HP
J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
[TBL] [Abstract][Full Text] [Related]
69. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
70. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
[TBL] [Abstract][Full Text] [Related]
71. Preparation and characterization of PLGA-β-CD polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line.
Gorjikhah F; Azizi Jalalian F; Salehi R; Panahi Y; Hasanzadeh A; Alizadeh E; Akbarzadeh A; Davaran S
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):432-440. PubMed ID: 27002986
[TBL] [Abstract][Full Text] [Related]
72. [Inhibition of A549 cells by polybutylcyanoacrylate nanoparticles loaded with antisense oligodeoxynucleotide of hTERT mRNA].
Zhang YY; Fu CJ; Zhang ZZ
Yao Xue Xue Bao; 2006 May; 41(5):446-51. PubMed ID: 16848322
[TBL] [Abstract][Full Text] [Related]
73. The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2'-O-methyl-RNA directed against telomerase in lung cancer cells.
Taetz S; Nafee N; Beisner J; Piotrowska K; Baldes C; Mürdter TE; Huwer H; Schneider M; Schaefer UF; Klotz U; Lehr CM
Eur J Pharm Biopharm; 2009 Jun; 72(2):358-69. PubMed ID: 18703137
[TBL] [Abstract][Full Text] [Related]
74. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
75. Temozolomide loaded PLGA-based superparamagnetic nanoparticles for magnetic resonance imaging and treatment of malignant glioma.
Ling Y; Wei K; Zou F; Zhong S
Int J Pharm; 2012 Jul; 430(1-2):266-75. PubMed ID: 22486964
[TBL] [Abstract][Full Text] [Related]
76. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ
Amin FU; Shah SA; Badshah H; Khan M; Kim MO
J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812
[TBL] [Abstract][Full Text] [Related]
77. Magnetic nanoparticles-loaded PLA/PEG microspheres as drug carriers.
Frounchi M; Shamshiri S
J Biomed Mater Res A; 2015 May; 103(5):1893-8. PubMed ID: 25203941
[TBL] [Abstract][Full Text] [Related]
78. Magnetic Nanoparticles Associated PEG/PLGA Block Copolymer Targeted with Anti-Transferrin Receptor Antibodies for Alzheimer's Disease.
Cui N; Lu H; Li M
J Biomed Nanotechnol; 2018 May; 14(5):1017-1024. PubMed ID: 29883571
[TBL] [Abstract][Full Text] [Related]
79. Preparation and in vitro evaluation of protective effects of Silibinin-loaded polymeric micelles on human hair against UV-B radiation.
Zadeh BSM; Akbari H; Salimi A
J Cosmet Dermatol; 2024 May; 23(5):1816-1827. PubMed ID: 38193246
[TBL] [Abstract][Full Text] [Related]
80. Magnetic nanoparticle formulation for targeted delivery of chemotherapeutic irinotecan to lungs.
Kulkarni P; Rajadurai M; Sevilimedu A; Basaveni S; Yellanki S; Medishetti R; Saxena U
Drug Deliv Transl Res; 2018 Oct; 8(5):1450-1459. PubMed ID: 29717474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]